Menu Search
Equities

China NT Pharma Group Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
1011:HKG.HZ

China NT Pharma Group Co Ltd

Actions
  • Price (HKD)0.75
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change+219.15%
  • Beta0.2698
Data delayed at least 15 minutes, as of Feb 13 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

China NT Pharma Group Co Ltd is an investment holding company principally engaged in the digital services businesses. The Company operates its business through two segments. The Digital Services segment is mainly engaged in the provision of marketing and promotion in relation to bone health knowledge. The Sales Agency Service segment is mainly engaged in acting as agent for clients to sell medical and health-related products to external customers.

  • Revenue in HKD (TTM)21.13m
  • Net income in HKD-80.33m
  • Incorporated2010
  • Employees21.00
  • Location
    China NT Pharma Group Co LtdNo. 1 Hualing StreetSuzhou Industrial ParkSUZHOU 200020Hong KongHKG
  • Phone+852 28081606
  • Fax+852 25089459
  • Websitehttp://www.ntpharma.com
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		1011:HKG since
announced		Transaction
value
Zhong He Qun Lian LtdAnnounced28 Apr 202528 Apr 2025Announced87.50%4.44m
Yue Hua LtdAnnounced28 Apr 202528 Apr 2025Announced87.50%4.15m
Junbinxiongdi LtdAnnounced28 Apr 202528 Apr 2025Announced87.50%5.59m
Data delayed at least 15 minutes, as of Feb 16 2026 03:06 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.